We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NXS market cap is 40.84M. The company's latest EPS is USD -0.0558 and P/E is -2.51.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.1M | 3.8M | 9.09M | 11.75M | 22.28M |
Operating Income | -12.5M | -12.19M | -9.47M | -12.7M | -15.95M |
Net Income | -14.35M | -11.91M | -9.35M | -12.68M | -16.27M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 22.7M | 23.64M | 13.72M | 12.46M | 17.9M |
Total Liabilities | 3.34M | 4.73M | 2.95M | 4.42M | 5.08M |
Total Equity | 19.36M | 18.91M | 10.77M | 8.04M | 12.82M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -12.33M | -11.91M | -8.26M | -11.79M | -15.06M |
Investing | -1.61M | -687k | -716k | -476k | -885k |
Financing | 23.69M | 10.71M | 1.43M | 10.25M | 20.11M |
Market Cap | 40.84M |
Price to Earnings Ratio | -2.51 |
Price to Sales Ratio | 1.83 |
Price to Cash Ratio | 4.42 |
Price to Book Ratio | 3.19 |
Dividend Yield | - |
Shares Outstanding | 291.7M |
Average Volume (1 week) | 125.13k |
Average Volume (1 Month) | 206.97k |
52 Week Change | -44.00% |
52 Week High | 0.50 |
52 Week Low | 0.115 |
Spread (Intraday) | 0.14 (97.14%) |
Company Name | Next Science Limited |
Address |
level 14 sydney, new south wales 2000 |
Website | https://www.nextscience.com/ |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions